• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Medical therapy for secondary prevention of stroke.

作者信息

Regesta Giovanni

机构信息

Department of Neurology, Stroke Unit, San Martino Hospital, 16132 Genoa, Italy.

出版信息

Clin Exp Hypertens. 2002 Oct-Nov;24(7-8):555-62. doi: 10.1081/ceh-120015332.

DOI:10.1081/ceh-120015332
PMID:12450231
Abstract

The identification and modification of risk factors for stroke and their appropriate management can lead to reduction of stroke incidence. The real impact on recurrences of risk factors associated with lifestyles has not been thoroughly investigated, and the possible role of their modification in secondary prevention is principally extrapolated from primary prevention studies. On the other hand, several pathological conditions such as hypertension, atrial fibrillation, carotid stenosis, and diabetes are known to favour the risk of recurrence. Available antiplatelet regimens offer only partial protection against stroke and more efficacious antithrombotic agents would be useful. There is no doubt that warfarin is effective in preventing recurrence in stroke patients with atrial fibrillation. However, a careful etiological subtyping of stroke is recommended before starting treatment.

摘要

相似文献

1
Medical therapy for secondary prevention of stroke.
Clin Exp Hypertens. 2002 Oct-Nov;24(7-8):555-62. doi: 10.1081/ceh-120015332.
2
Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.抗凝剂与抗血小板治疗对预防非风湿性心房颤动且有卒中或短暂性脑缺血发作病史患者的卒中作用比较
Cochrane Database Syst Rev. 2004 Oct 18(4):CD000187. doi: 10.1002/14651858.CD000187.pub2.
3
Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke.抗血小板和抗凝策略在缺血性卒中的预防和治疗中的应用。
Curr Pharm Des. 2012;18(33):5261-72. doi: 10.2174/138161212803251961.
4
Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.抗凝剂与抗血小板治疗对预防非风湿性心房颤动且有卒中或短暂性脑缺血发作史患者的卒中作用比较
Cochrane Database Syst Rev. 2000(2):CD000187. doi: 10.1002/14651858.CD000187.
5
Incidence and prevention of ischemic stroke following myocardial infarction: review of current literature.心肌梗死后缺血性卒中的发病率及预防:当前文献综述
Cerebrovasc Dis. 2006;22(5-6):331-9. doi: 10.1159/000094847. Epub 2006 Aug 3.
6
How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?中风、短暂性脑缺血发作或颈动脉内膜切除术后的血管风险管理效果如何?
Cerebrovasc Dis. 2007;23(2-3):156-61. doi: 10.1159/000097053. Epub 2006 Nov 16.
7
Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.抗血栓治疗的使用率低导致房颤患者的缺血性卒中发生率较高。
Int J Stroke. 2012 Feb;7(2):112-7. doi: 10.1111/j.1747-4949.2011.00667.x. Epub 2011 Nov 22.
8
[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].[心房颤动抗栓治疗指南:意大利止血与血栓形成学会的观点]
Haematologica. 2001 Sep;86(9 Suppl):12-3.
9
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?中风和短暂性脑缺血发作的二级预防:更多的血小板抑制是答案吗?
Circulation. 2007 Mar 27;115(12):1615-21. doi: 10.1161/CIRCULATIONAHA.106.653741.
10
Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.非瓣膜性心房颤动患者华法林的显著低使用率:来自中国国家卒中登记研究的结果。
J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1157-63. doi: 10.1016/j.jstrokecerebrovasdis.2013.10.006. Epub 2013 Dec 2.